Medical Director Receives Certificates of Recognition
Posted: Dec 02, 2011


InCyte Pathology’s Laboratory Medical Director, David C. Hoak, M.D., recently received the College of American Pathologists (CAP) Laboratory Medical Director Advanced Practical Pathology Program, as well as the Breast Predictive Factors Testing (BPFT)Advanced Practical Pathology Program Certificate of Recognition. The BPFT program was designed specifically for pathologists with intermediate or higher skill level in breast predictive factors testing. This selective training program covers the accurate performance and interpretation of breast cancer predictive factors in accordance with the guidelines of the American Society of Clinical Oncology and the College of American Pathologists (ASCO/CAP).
The College of American Pathologists is the leading organization of board-certified pathologists, serving patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine.  CAP advanced training programs focus on providing pathologists with practical skills, tools, and techniques for implementation in their laboratories to ensure more effective results for patients, as well as compliance with current laboratory guidelines.
A majority of Dr. Hoak’s training was on the performance and interpretation of prognostic and predictive factors such as estrogen receptor (ER), progesterone receptor (PgR), and Human Epidermal growth factor Receptor 2 (HER2) in breast cancer diagnostic pathology.   These factors determine the clinical course of disease for the patient and their suitability for specific treatments. Given the critically important implications that these factors have in terms of subsequent selection of therapy and ultimately the clinical outcomes for a patient, ensuring testing accuracy is a high priority for InCyte Pathology. 
“The greatest and most important benefit is providing patients the assurance that their breast biopsy results are accurate,” explains Dr. Hoak.  “Patients can feel confident that the clinician’s treatment decisions will also be accurate and effective.”

« back